# OnCo record monarche (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/monarche/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "monarche", "NCT03155997" ;
  schema:name "monarchE"@en ;
  schema:description "The first CDK4/6 inhibitor to reduce recurrence after surgery in high-risk hormone-positive breast cancer."@en ;
  schema:url <https://onco.cc/trials/monarche/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03155997> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-07-12" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:people <https://onco.cc/people/stephen-johnston/>, <https://onco.cc/people/nadia-harbeck/>, <https://onco.cc/people/miguel-martin/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-monarche-lancet-oncol-2023/>, <https://onco.cc/key-papers/paper-monarche-ann-oncol-2026-update/> .